Numerous scientific studies in recent years have shown significant skin and gut dysbiosis
among patients with psoriasis. A significant decrease in microbiome alpha-diversity …

The skin barrier is broadly composed of two elements—a physical barrier mostly localised in
the epidermis, and an immune barrier localised in both the dermis and epidermis. These two …

Psoriasis is a chronic inflammatory skin disease with autoimmune pathogenic characteristics
and is caused by chronic inflammation, which results in uncontrolled keratinocyte growth …

Psoriasis is a chronic, immune-mediated inflammatory disease that affects around 125
million people worldwide. Several studies concerning the gut microbiota composition and its …

Background Identification of those at risk of more severe psoriasis and/or associated
morbidities offers opportunity for early intervention, reduced disease burden and more cost …

The close relationship between the intestine and the skin has been widely stated, seen from
gastrointestinal (GI) disorders often accompanied by skin manifestations. Exactly how the …

With advancement in human microbiome research, an increasing number of scientific
evidences have endorsed the key role of both gut and skin microbiota in the pathogenesis of …

The human microbiome encodes more than three million genes, outnumbering human
genes by more than 100 times, while microbial cells in the human microbiota outnumber …

Psoriasis is a chronic, immune-mediated, inflammatory disease primarily affecting the skin. It
is currently coming to light that patients with psoriasis have disrupted intestinal barrier and …

Background Increasing evidence has shown that alterations in the intestinal microbiota play
an important role in the pathogenesis of psoriasis. The existing relevant studies focus on …